AccessibilityHelpAbout Us
Ventana Global logo

Ventana Global(OTC) VNTA

Market Cap$2.64MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)+2,155%
5 Year-37%
1 Year+126%
1 Month+0%
$0.05
+0.00%
+0.00Today
Ventana Global last closing stock price
MetricPriceDate
Last closeUSD 0.052026-09-14
Ventana Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.052026-08-27
1 month+0%USD 0.052026-08-11
3 month-22.22%USD 0.062026-06-16
Year to date+32.79%USD 0.042025-12-29
1 year+125.81%USD 0.022025-08-20
3 year+11.36%USD 0.042023-09-15
5 year-37.18%USD 0.082021-09-15
Since inception+2,154.95%USD 0.002006-11-13

Ventana Global Financials at a Glance

Market Cap

$2.64MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$114.58K

Net Income (TTM)

$86.14K

EPS (TTM)

$0.00

P/E Ratio

23.33

Dividend

$0.00

Beta (Volatility)

-0.22 (Low)

Price

$0.05

Volume

50

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.02 - $0.08

Estimated Earnings Date

N/A

VNTA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventana Global

Ventana Biotech, Inc. is an emerging biotechnology company focused on the lifecycle of drug candidates for personalized medicine. The company specializes in addressing obesity and related medical conditions through innovative products, including a unique medicated chewing gum formulation.

Products and Services
  • Medicated chewing gum for obesity management
  • Lower-dosage version for over-the-counter sales
  • Higher-dosage variant for pharmacy distribution
Growth Outlook
  • Recent quarterly revenue increased significantly to 47,721
  • Trailing twelve months (TTM) net income shows a positive trend
  • Expansion into the over-the-counter market is anticipated
Financial Highlights
  • TTM revenue of 80,801 reflects growth potential
  • Operating income margin improved to 87.99%
  • Net income margin stands at 75.18%
Ventana Biotech, Inc. operates with a clear focus on developing innovative solutions for obesity management, leveraging proprietary formulations that combine natural extracts. The company's strategic approach includes targeting both over-the-counter and pharmacy markets, which positions it well for future growth. Recent financial performance indicates a strong upward trajectory, particularly in revenue and profitability margins, suggesting that the company is on a path to capitalize on its unique offerings. With a commitment to personalized medicine, Ventana Biotech is poised to make significant contributions to the healthcare landscape.
AI Generated • Sep 2, 2026

Industry

Diversified Financial Services

Sector

Financials

Employees

1

CEO

Stephen D. Replin, MBA, CPA

Website

www.ventana.global

Headquarters

Denver, CO 80206, US

VNTA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

87.99%

Net Income Margin

75.18%

Return on Equity

-159.72%

Return on Capital

175.99%

Return on Assets

141.00%

Earnings Yield

4.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.64MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

53.78M

Volume

50

Avg. Volume

315.968

Financials (TTM)

Gross Profit

$0.00

Operating Income

$100.82K

EBITDA

$100.82K

Operating Cash Flow

$1.66K

Capital Expenditure

$0.00

Free Cash Flow

$1.66K

Cash & ST Invst.

$61.09K

Total Debt

$113.08K

Ventana Global Performance Analysis

Ventana Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20232023-12-31USD 31,845N/A
20242024-12-31USD 41,36229.9%
20252025-12-31USD 114,577177.0%
Ventana Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30N/A
Q22025-09-308056.9%
Q32025-12-31-26.9%
Q42025-12-31-98.3%
Ventana Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.00N/A
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.000.0%
20252025-12-31USD 0.00300.0%
Ventana Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30N/A
Q22025-09-30N/A
Q32025-12-31-40.0%
Q42025-12-31-100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$47.72K

+5865.1%

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.64MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.64M

N/A

Employees

1

N/A

Net Income

$31.93K

+2099.4%

EBITDA

$46.61K

+3018.3%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$61.09K

+583.0%

Total Debt

$113.08K

+14.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$113.08K

+14.6%

Return on Assets

1.41%

N/A

Return on Invested Capital

-1.87%

N/A

Free Cash Flow

$1.66K

N/A

Operating Cash Flow

$1.66K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALDAAtlantica, Inc.
$1.00+0.00%
HBIEHai Jia International Limited Company
$0.00+0.00%
AAPTAll American Pet Company, Inc.
$0.00+0.00%
MNZOManzo Pharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.84+1.97%
INTCIntel
$97.14-0.05%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$102.32+1.18%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$51.10-1.22%

Questions About VNTA

What is the current price of Ventana Global?

Ventana Global is trading at $0.05 per share.

What is the 52-week range for Ventana Global?

Over the past 52 weeks, Ventana Global has traded between $0.02 and $0.08.

How much debt does Ventana Global have?

As of the most recent reporting period, Ventana Global reported total debt of $114.06K.

How much cash does Ventana Global have on hand?

Ventana Global reported $77.80K in cash and cash equivalents in its most recent financial results.

What is Ventana Global’s dividend yield?

Ventana Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services